Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Ritter

Showing results (11-20 of 164) with videos related to

Pageof 17
Sort By:
British Journal of Clinical Pharmacology|November 18, 2009
Uncertain risks of drug related harms, the precautionary principle and limitations of meta-analysisJ M Ritter
British Journal of Clinical Pharmacology|June 25, 2010
Dysrhythmias associated with cocaine overdoseJ M Ritter
British Journal of Clinical Pharmacology|August 22, 2009
Communicating about potential drug harms: safety implications for patientsJ M Ritter
British Journal of Clinical Pharmacology|March 18, 2010
Drug code names and other ethics-related mattersJ M Ritter
British Journal of Clinical Pharmacology|August 23, 2008
Chronic disease: when in doubt, consider accrual into a randomized controlled trial (RCT)J M Ritter
British Journal of Pharmacology|October 1, 1984
Prostanoid synthesis by aortic rings in human blood: selective increase of prostacyclin mediated by a serum factorJ M Ritter
British Journal of Clinical Pharmacology|February 7, 2008
Sensitivity: real (interferons, odorants) and imagined (homeopathy)J M Ritter
British Journal of Clinical Pharmacology|March 13, 2008
Minimising harm: human variation and adverse drug reactions (ADRs)J M Ritter
British Journal of Clinical Pharmacology|October 2, 2008
Prediction and reverse prediction in therapeutics and toxicologyJ M Ritter
The New England Journal of Medicine|April 4, 1991
Nitroglycerin to treat acute loss of visionJ M Ritter
Pageof 17

Showing results (11-20 of 164) with videos related to

Sort By:
Pageof 17
British Journal of Clinical Pharmacology|November 18, 2009
Uncertain risks of drug related harms, the precautionary principle and limitations of meta-analysisJ M Ritter
British Journal of Clinical Pharmacology|June 25, 2010
Dysrhythmias associated with cocaine overdoseJ M Ritter
British Journal of Clinical Pharmacology|August 22, 2009
Communicating about potential drug harms: safety implications for patientsJ M Ritter
British Journal of Clinical Pharmacology|March 18, 2010
Drug code names and other ethics-related mattersJ M Ritter
British Journal of Clinical Pharmacology|August 23, 2008
Chronic disease: when in doubt, consider accrual into a randomized controlled trial (RCT)J M Ritter
British Journal of Pharmacology|October 1, 1984
Prostanoid synthesis by aortic rings in human blood: selective increase of prostacyclin mediated by a serum factorJ M Ritter
British Journal of Clinical Pharmacology|February 7, 2008
Sensitivity: real (interferons, odorants) and imagined (homeopathy)J M Ritter
British Journal of Clinical Pharmacology|March 13, 2008
Minimising harm: human variation and adverse drug reactions (ADRs)J M Ritter
British Journal of Clinical Pharmacology|October 2, 2008
Prediction and reverse prediction in therapeutics and toxicologyJ M Ritter
The New England Journal of Medicine|April 4, 1991
Nitroglycerin to treat acute loss of visionJ M Ritter
Pageof 17